الرئيسية > أدوية > زينثا 1000وحدة فيال

سعر زينثا 1000وحدة فيال
Xyntha 1000 i.u. lyophilized powder vial الجديد | 2023

زينثا 1000وحدة فيال

سعر دواء زينثا 1000وحدة فيال

معلومات سريعة عن زينثا 1000وحدة فيال

الشركة

wyeth pharmaceuticals company > pfizer

نوع الدواء

حقن حقن

اخر تحديث للسعر

1/5/2022, 1:19:34 AM

عدد الزيارات

564

لاظهار سعر زينثا 1000وحدة فيال الجديد

فضلا اضغط بالاسفل


أسئلة شائعة عن زينثا 1000وحدة فيال

كيف يستعمل دواءزينثا 1000وحدة فيال ؟

يستعمل دواء زينثا 1000وحدة فيال xyntha 1000 i.u. lyophilized powder vial blood-coagulation factor blood-coagulation factor

xyntha� antihemophilic factor (recombinant) is indicated in adults and children with hemophilia a (congenital factor viii deficiency or classic hemophilia) for control and prevention of bleeding episodes and for perioperative management. - -when blood vessels are cut or damaged the loss of blood from the system must be stopped before shock and possible death occur. this is accomplished by solidification of the blood a process called coagulation or clotting. - -a blood clot consists of -a plug of platelets enmeshed in a -network of insoluble fibrin molecules. -the extrinsic pathway - -damaged cells display a surface protein called tissue factor (tf) -tissue factor binds to activated factor 7. -the tf-7 heterodimer is a protease with two substrates: -factor 9 and -factor 10 -the intrinsic pathway

ما هي تركيبة دواء زينثا 1000وحدة فيال ?

تركيبة دواءزينثا 1000وحدة فيال xyntha 1000 i.u. lyophilized powder vial

يتركب هذا الدواء من :blood-coagulation factor viii

ما هي الشركة المنتجة لدواءزينثا 1000وحدة فيال ؟

الشركة المنتجة لدواءزينثا 1000وحدة فيال xyntha 1000 i.u. lyophilized powder vial

هذا الدواء من انتاج شركة wyeth pharmaceuticals company > pfizer

ما هي جرعة دواءزينثا 1000وحدة فيال ؟

جرعة دواءزينثا 1000وحدة فيال


All You Need To Know About xyntha 1000 i.u. lyophilized powder vial

Welcome to Dlildwa, specifically the page of xyntha 1000 i.u. lyophilized powder vial.

  • xyntha 1000 i.u. lyophilized powder vial is a highly effective medication that is used to treat a variety of conditions. It contains blood-coagulation factor viii, which is the active ingredient that provides the drug's therapeutic effect.
  • This medication is typically prescribed to treat blood-coagulation factor, which include xyntha� antihemophilic factor (recombinant) is indicated in adults and children with hemophilia a (congenital factor viii deficiency or classic hemophilia) for control and prevention of bleeding episodes and for perioperative management. - -when blood vessels are cut or damaged the loss of blood from the system must be stopped before shock and possible death occur. this is accomplished by solidification of the blood a process called coagulation or clotting. - -a blood clot consists of -a plug of platelets enmeshed in a -network of insoluble fibrin molecules. -the extrinsic pathway - -damaged cells display a surface protein called tissue factor (tf) -tissue factor binds to activated factor 7. -the tf-7 heterodimer is a protease with two substrates: -factor 9 and -factor 10 -the intrinsic pathway. It is known for its potent formula and fast-acting nature, making it a popular choice among healthcare providers and patients alike.
  • xyntha 1000 i.u. lyophilized powder vial is produced by wyeth pharmaceuticals company > pfizer and is available in the market at a price of 5913. It is one of the most popular and trusted medications in its class, and is often recommended by doctors for its safety and effectiveness.
  • Before taking , it is important to consult with your healthcare provider to ensure that it is safe and appropriate for your condition. Be sure to follow the dosage instructions carefully, and do not exceed the recommended dose.
  • If you have any questions or concerns about xyntha 1000 i.u. lyophilized powder vial or any other medications, please don't hesitate to contact us. Our team of healthcare professionals is here to help you make informed decisions about your health and wellness.

  • بدائل دواء زينثا 1000وحدة فيال

    15+
    عدد البدائل
    0+
    زائر
    blood-coagulation factor viii
    المادة الفعالة

    تم استعراض بدائل هذا الدواء 244 مرة


    injection
    blood-coagulation factor viii

    dried factor viii fraction 8y 250i.u./10ml vial

    اذهب الى الدواء
    injection
    blood-coagulation factor viii

    kogenate-fs 250 iu i.v. infusion vial 2.5 ml

    اذهب الى الدواء
    injection
    blood-coagulation factor viii

    dried factor viii fraction 8y 500i.u./20ml vial

    اذهب الى الدواء
    injection
    blood-coagulation factor viii

    koate-dvi 500 iu i.v. vial 5 ml

    اذهب الى الدواء
    injection
    blood-coagulation factor viii

    kogenate-fs 500 iu i.v. infusion vial 2.5 ml

    اذهب الى الدواء

    انقر لنسخ رابط مشاركة معلومات وسعر هذا الدواء